Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Lean tirzepatide when: Maximum weight loss is the goal (target greater than 20%) You have T2D with significant insulin resistance (SURPASS-2: 11.2 kg tirzepatide vs 5.7 kg semaglutide) You have moderate-to-severe obstructive sleep apnea with obesity (Zepbound is the only FDA-approved pharmacotherapy) You plateaued on semaglutide after 12+ months You have MASH and need the drug with the strongest resolution data (SYNERGY-NASH: 44 to 62% resolution) Your insurance covers Zepbound or Mounjaro You tolerated the 2.5 mg starting dose well during a prior trial Lean semaglutide when: You have established cardiovascular disease or high CV risk
Itching is typically mild and short-lived
Approved by the FDA in 2022 for the treatment of type 2 diabetes, its a weekly injection thats proven so effective for weight loss that its been fast-tracked by the FDA for approval for treating obesity but has not been given the green light just yet
Your digestive system naturally makes hydrogen sulfide gas when breaking down food
FeelGood's published Terms explicitly state that approval is not guaranteed
Each vial is prepared to support precise measurement and repeatable experimental outcomes in controlled laboratory environments
US$ 20.27
US$ 22.68
US$ 29.69
US$ 21.51
US$ 22.97
US$ 28.63
US$ 20.26
